A problem-solving venture capitalist, Chris Moehle has extensive knowledge and experience in robotics. Chris Moehle serves as a board member at technology-based companies, including Ariel Precision Medicine, which develops diagnostic solutions.
A clinical decision support platform developed by Ariel, ADVANCE(R) simplifies diagnosis of pancreatitis (inflammation of the pancreas) in its early stages and enables more accurate treatment options. Common treatments for pancreatitis address symptoms such as upper abdominal pain, fever, nausea, rapid pulse, weight loss, and/or steatorrhea (oily and unpleasant smelling stool).
However, in most cases of complex disorders like pancreatitis, there is not a single cause and underlying issues may remain untreated. ADVANCE, with its AI-powered technology, integrates evidence-based knowledge with deep genetic sequencing to efficiently diagnose the condition and provide reports that can be utilized by health professionals. ADVANCE results in a personalized diagnosis by integrating multiple factors, including the patient's genetics, environmental and lifestyle factors, and medical history.
